KELOWNA, BC, Aug. 14, 2019 /CNW/ – PRESS RELEASE – Valens GroWorks Corp., a vertically integrated provider of extraction products and services, including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, has announced that it has been added to The Cannabis ETF (NYSE: THCX), which trades on the New York Stock Exchange.
« Valens’ inclusion in The Cannabis ETF will provide us with a new opportunity to broaden our reach and increase our profile among investors in the U.S. who are looking for the value our platform provides, particularly as we continue to accelerate our business activities globally » said Tyler Robson, CEO of Valens.
THCX tracks the Innovation Labs Cannabis Index, which is a modified market capitalization weighted index, with a portfolio of 36 stocks that are expected to benefit from growth of the legal marijuana, CBD and hemp industries. Valens’ inclusion is part of THCX’s expansion to include various cannabis industry sub-themes, such those at the crossroads of science and technology, which is intended to appeal to investors who are looking for differentiated exposure outside of a traditional seed-to-sale story. The index rebalances on a monthly basis and it is currently considered the lowest cost passively managed US-listed cannabis ETF.]]>